AKAnteneh Ayelign Kibret

Anteneh Ayelign Kibret

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anteneh Ayelign Kibret has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Total treatment interval and quality of life of women living with breast cancer in Ethiopia: the mediating role of financial toxicity

    by Anteneh Ayelign Kibret, Heng Jiang, Edom Seife Woldetsadik, Miliyard Demeke Tafese, Biniyam Tefera Deressa, Chaojie Liu

    Purpose: Delays in breast cancer care are common in low-resource settings and may adversely affect patients’ quality of life (QoL). Prolonged total treatment interval (TTI) can also impose substantial financial hardship. This study aimed to get insights into the potential mechanisms of how prolonged treatment interval impacts QoL through a mediation model and explore the mediating role of financial toxicity (FT) among Ethiopian women with breast cancer. Methods: A cross-sectional study was conducted among 458 women with histologically confirmed breast cancer receiving treatment at three oncology centers in Ethiopia (Black Lion, Jimma, and Hiwot Fana Hospitals) between July and September 2024. QoL was assessed using the EORTC QLQ-C30, where higher functioning and global health scores indicate better QoL, while higher symptom scores reflect greater symptom burden. Financial toxicity was measured using the COST–FACIT tool, with lower scores indicating greater financial hardship. TTI was calculated as days from symptom recognition to treatment initiation. Mediation and moderated mediation analyses were performed using PROCESS v4.3 for R, controlling for sociodemographic and clinical factors. Results: Of 456 (99.6%) women with complete data, 71% experienced delayed treatment initiation (> 90 days). The mean (SD) global health status and EORTC QLQ-C30 summary scores were 81.2 (19.9) and 85.8 (15.2), respectively. Longer TTI was significantly associated with poorer QoL, with declines observed in both global health status ( r = − 0.22, p < 0.001) and the QLQ-C30 summary score ( r = − 0.17, p < 0.001). In multivariable models, longer TTI (> 90 days) was associated with lower FT scores, indicating greater financial hardship (β = −2.72, p = 0.001). Financial toxicity was positively associated with GHS scores (β = 0.63, p < 0.001). The indirect effect of TTI on GHS through financial toxicity was significant (β = −1.70, 95% CI [− 2.94, − 0.66]), while direct and total effects were not. Similar patterns were observed for the EORTC QLQ-C30 summary and functional/symptom domains. Cancer stage did not significantly moderate the indirect pathway. Conclusion: Prolonged TTI impair quality of life among women with breast cancer in Ethiopia primarily through increased financial hardship rather than direct clinical effects. Interventions aimed at reducing delays and mitigating financial burden may enhance patient well-being and treatment outcomes in low-resource settings.

  • Open Access

    Association between time to treatment and financial toxicity among women with breast cancer in Ethiopia: a multicentre study in a low-resource setting

    by Anteneh Ayelign Kibret, Heng Jiang, Edom Seife Woldetsadik, Miliyard Demeke Tafese, Biniyam Tefera Deressa, Chaojie Liu

    Purpose: Breast cancer imposes a substantial financial burden on patients, especially in low-income countries like Ethiopia where out-of-pocket (OOP) payments dominate health financing. This study aimed to assess the association between time to treatment initiation and financial toxicity (FT), among women with breast cancer in Ethiopia. Methods: A cross-sectional study was conducted from July to September 2024 among 458 women receiving breast cancer care at three tertiary hospitals in Ethiopia. Participants were interviewed using a validated Amharic version of the COST-FACIT tool, with additional data obtained from interviews and clinical records. The primary outcome was FT score, which ranged from 0 to 44, with a lower score indicating greater financial toxicity. Multivariable linear regression was used to assess the association between FT and the total treatment interval (TTI) from symptom recognition to treatment initiation, adjusting for sociodemographic, clinical, health insurance, and cost-coping behavioral factors . Results: The median FT score was 10 (IQR:5 to 16), indicating a high level of financial toxicity among the study participants. Most participants (71%) had a TTI longer than 90 days, which was associated with higher financial toxicity (median FT score 9 compared with 14 in those with ≤ 90 TTI days, p < 0.001). Longer TTI was a significant predictor ( B = –2.50; 95% CI: –4.06 to –0.95; p = 0.002) of higher financial toxicity, after adjustment for variations of covariates. Other significant predictors of higher financial toxicity included younger age (< 40 years: B = –4.37; p = 0.001; 40–59 years: B = –3.53; p = 0.003), lower income (≤ 2,100 ETB: B = –5.40; 2,101–3,254 ETB: B = –3.91; p < 0.001), rural residence ( B = –2.28; p = 0.039), on active treatment ( B = –3.59; p = 0.001), and reliance on borrowed/assisted financing for OOP ( B = –4.59; p < 0.001). There also existed FT disparities across the three hospitals. Conclusion: Financial toxicity is evident in Ethiopian women with breast cancer, particularly among those with lower socioeconomic status. Longer TTI is associated with higher financial toxicity. These findings highlight the limited role of the current health insurance arrangement in addressing the level and inequality of financial toxicity associated with breast cancer care in Ethiopia.


  • Open Access

    Factors Influencing Time to Treatment Initiation for Breast Cancer in Ethiopia

    by Anteneh Ayelign Kibret, Jason Jiang, Edom Seife Woldetsadik, Miliyard Demeke Tafese, Biniyam Tefera Deressa, Chaojie Liu

    Background: Breast cancer remains a major public health concern in Ethiopia, with timely access to care critical for improving outcomes. This study examined factors associated with delays in the breast cancer care pathway. Methods: This cross‐sectional study collected data from 458 women with histologically confirmed breast cancer between July and September 2024 at three tertiary hospitals. Data were collected through structured interviews and clinical records. Five time intervals from symptom detection to treatment initiation were analyzed using the Model of Pathways to Treatment. Factors were categorized using Andersen's Behavioral Model, and Accelerated Failure Time (AFT) models were used to estimate time ratios (TRs) with 95% confidence intervals (CIs). Results: Rural residence (TR = 1.84; 95% CI: 1.20–2.80) and painless breast mass (TR = 1.94; 95% CI: 1.26–3.00) were linked to longer delays from symptom recognition to first healthcare contact. Low breast cancer literacy and consulting traditional healers before diagnosis were consistently associated with prolonged delays. Consulting ≥ 3 providers extended both intervals, from first healthcare contact to diagnosis (TR = 3.13; 95% CI: 1.96–4.98) and symptom detection to diagnosis (TR = 1.63; 95% CI: 1.02–2.62). Delays were also associated with first providers failing to suspect or refer for cancer. Longer diagnosis‐to‐treatment intervals were observed among unmarried women, low‐income groups, and those using traditional healing post‐diagnosis. Older women (≥ 60 years) experienced shorter delays in initiating treatment (TR = 0.62; 95% CI: 0.41–0.93). Conclusion: Delays in breast cancer care in Ethiopia are driven by individual, sociocultural, and systemic barriers. Multilevel interventions are needed to promote early detection and timely treatment.


  • Open Access

    Patient journey and timeliness of care for patients with breast cancer in Africa: a scoping review protocol

    by Anteneh Ayelign Kibret, Heng Jiang, Haifeng Yang, Chaojie Liu

    Introduction Cancer is the leading cause of death worldwide, with breast cancer being one of the most commonly diagnosed types. Low-income and middle-income countries account for nearly half of all breast cancer cases and related fatalities. In Africa, mortality rates are higher and survival rates are lower compared with developed countries. Timeliness of care is a critical aspect of healthcare, but various studies and healthcare systems use different criteria and methods to measure it. Assessing the breast cancer care pathway and understanding the determinants of delayed care are essential for effective interventions. Therefore, this scoping review aims to evaluate the methods used to measure the timeliness of breast cancer care, identify specific points in the care pathway where delays are most frequently reported, and examine the factors affecting the timeliness of breast cancer care in Africa. Methods and analysis We will conduct this scoping review using the Arksey and O’Malley framework endorsed by the Joanna Briggs Institute. A scoping review of articles written in English concerning the timeliness of breast cancer care in the African context will be undertaken. Six electronic databases (MEDLINE, EMBASE, CINAHL, SCOPUS, WEB Of SCIENCE and PsycINFO) will be searched to identify published literature on timeliness of breast care in Africa. Two reviewers will independently screen the articles at both the abstract and full-text stages, guided by predetermined inclusion and exclusion criteria. The full texts of identified studies will be further examined and charted using a data extraction form guided by the Model of Pathways to Treatment framework. Publications describing the time to diagnosis and its associated factors in the contexts of breast cancer will be considered for inclusion, with no restrictions based on date of publication. Studies that are published in languages other than English and that do not focus on the timeliness of care or time-related aspects within the care pathway will be excluded. Evidence will be narratively synthesised and analysed. Ethics and dissemination Ethical approval is not needed as this scoping review does not involve collecting data from human participants. The results produced from this review will be submitted to a scientific peer-reviewed journal for publication and will be presented at scientific meetings.


  • Open Access

    An unacceptably high burden of anaemia and it’s predictors among young women (15–24 years) in low and middle income countries; set back to SDG progress

    by Mehari Woldemariam Merid, Dagmawi Chilot, Adugnaw Zeleke Alem, Fantu Mamo Aragaw, Melaku Hunie Asratie, Daniel Gashaneh Belay, Anteneh Ayelign Kibret

    Background: Anaemia is a major global public health problem, considerably affects young women in resource limited countries. The available researches on anaemia focused on children, pregnant women, or all women of reproductive age. However, women's biology and life experiences vary dramatically across 15 to 49 years, putting young women bear the higher burden of anaemia, mainly in low and middle income countries (LMICs). Therefore, this study assessed the burden of anaemia among young women (15–24 years) in 24 LMICs which conducted Demographic and Health Surveys (DHS) between 2016 and 2021.Method: Data analysis was carried out with STATA version 14. The forest plot was used to explore the pooled prevalence of anaemia. Multilevel binary logistic regression was fitted to accommodate the hierarchical nature of the DHS data. Accordingly, a model with lowest deviance (model III) was the best-fitted model. All variables with ap-value ≤ 0.2 in the bi-variable analysis were fitted in the multi-level multivariable model. Adjusted odds ratio with 95% CI andp < 0.05 were presented to declare statistical significance.Result: The pooled prevalence of anaemia among young (15–24 years) women in 24 LMICs was 41.58% (95%CI: 34.51, 48.65). Country wise, Mali (62.95%) and Rwanda (14.13%) constitute the highest and lowest prevalence of anaemia. In this study, young women who lived in the poorest wealth status, had no education, were underweight, perceived distance to the health facility a big problem, larger family size, and women who had ever terminated pregnancy were associated with increased odds of anaemia. Whereas, young women who were overweight and not breast feeding had decreased odds of anaemia.Conclusion: The unacceptably high burden of anaemia among young women setbacks the SDG target; to end all forms of malnutrition by 2030. Therefore, it is highly recommended to take relevant interventions to reduce the burden of anaemia targeted the young women who are uneducated, have low socio-economic status, limited access to health facilities, and lived in larger family size.


  • Open Access

    High burden of diabetes and prediabetes among cancer patients at University of Gondar comprehensive specialized hospital, Northwest Ethiopia

    by Haileab Fekadu Wolde, Meseret Derbew Molla, Hailu Aragie, Dagnew Getnet Adugna, Ephrem Tafesse Teferi, Endalkachew Belayneh Melese, Yohannes Awoke Assefa, Habtu Kifle, Yilkal Belete Worku, Daniel Gashaneh Belay, et al.

    Cancer and diabetes mellitus (DM) are diagnosed within the same individual more frequently and share common risk factors. Although diabetes among cancer patients may result in more aggressive clinical courses of cancer, there is limited evidence about its burden and associated factors. Hence, this study aimed to assess the burden of diabetes and prediabetes among cancer patients and its associated factors. Institution-based cross-sectional study was conducted at the University of Gondar comprehensive specialized hospital from 10 January to 10 March 2021. A systematic random sampling technique was used to select 423 cancer patients. The data was collected using a structured interviewer-administered questionnaire. Prediabetes and diabetes diagnosis was made based on World Health Organization (WHO) criteria. Bi-variable and multivariable binary logistic regression models were fitted to identify factors associated with the outcome. Adjusted Odds Ratio (AOR) with a 95% confidence interval was estimated to show the direction and strength of associations. Variables with a p-value less than 0.05 in the multivariable model were considered significantly associated with the outcome. The final analysis was based on 384 patients with cancer. The proportion of prediabetes and diabetes was 56.8% (95% CI 51.7, 61.7) and 16.7% (95% CI 13.3, 20.8), respectively. Alcohol consumption was found to increase the odds of elevated blood sugar among cancer patients (AOR: 1.96; 95%CI: 1.11, 3.46). The burden of prediabetes and diabetes is alarmingly high among cancer patients. Besides, alcohol consumption was found to increase the odds of having elevated blood sugar among cancer patients. Hence, it is essential to recognize cancer patients are at high risk of having elevated blood sugar and design strategies to integrate diabetes and cancer care.


  • Open Access

    Triple burden of malnutrition among mother–child pairs in low-income and middle-income countries: a cross-sectional study

    by Dagmawi Chilot, Daniel Gashaneh Belay, Mehari Woldemariam Merid, Anteneh Ayelign Kibret, Adugnaw Zeleke Alem, Melaku Hunie Asratie, Nahom Worku Teshager, Fantu Mamo Aragaw

    Objective This study aimed to assess the prevalence and determinants of the triple burden of malnutrition among mother–child pairs in low-income and middle-income countries. Design Cross-sectional study. Setting Low-income and middle-income countries. Participants Women and children. Primary outcome Triple burden of malnutrition (overweight/obese mother with undernourished and anaemic under 5 years child). Methods Data for this study were drawn from recent 22 low-income and middle-income countries Demographic and Health Surveys. A total weighted sample of 116 795 mother–child pairs was included in the study. STATA V.14.2 was used to clean, code and analyse the data. Multilevel logistic regression was employed to identify factors associated with the problem. Adjusted OR (AOR) with 95% CI and a p10 (AOR 1.17, 95% CI 1.08 to 1.26), delivery by caesarean section (AOR 1.93, 95% CI 1.83 to 2.03), the richest household (AOR 1.72, 95% CI 1.56 to 1.88), grand multiparous (AOR 1.62, 95% CI 1.46 to 1.81), age of child 36–47 months (AOR 1.77, 95% CI 1.64 to 1.90), at a pConclusion About 1 out of 10 households suffer from the triple burden of malnutrition in low-income and middle-income countries. This study revealed that several maternal, child, household and community-level factors have a significant impact on the triple burden of malnutrition among mother–child pairs.


  • Open Access

    Spatial variations and multi-level determinants of modern contraceptive utilization among young women (15–24 years) in Ethiopia: spatial and multi-level analysis of mini-EDHS 2019

    by Mehari Woldemariam Merid, Anteneh Ayelign Kibret, Adugnaw Zeleke Alem, Melaku Hunie Asratie, Fantu Mamo Aragaw, Dagmawi Chilot, Daniel Gashaneh Belay

    Introduction: There is tremendous regional inequalities and low uptake of modern contraceptives particularly among young women (15–24 years), characterized by high fertility but high unmet need for contraceptives in Ethiopia. Hence, the present study aimed at exploring the spatial distribution and the multi-level determinants of modern contraceptive use among young women in Ethiopia. Methods: This study was conducted using the 2019 Ethiopian demographic and health survey data on a weighted sample of 3,379 young women. STATA version 14 for the multi-level, and ArcGIS 10.7 and Sat Scan 9.6 for the spatial analysis were used. Spatial analysis was done to identify the hotspot areas of modern contraceptive use in Ethiopia. Multi-variable multi-level logistic regression was used for identifying determinants of modern contraceptive use and variables with a p-value < 0.05 were considered to be significant determinants. Result: The overall prevalence of modern contraceptive use among young women in Ethiopia was 17.23% (95% CI: 10.98, 23.47). The hotspots areas for modern contraceptive use were detected in the central and south-western Amhara, western and central Oromia, and western SNNPR regions. Whereas the Somali region, Dire dawa, and Harari cities were cold spot areas for modern contraceptive use. Being married (AOR = 18.5; 95% CI: 12.66, 27.27), parity (AOR = 4.82; 95% CI: 1.27, 18.32), having television (AOR = 2.39; 95%CI: 1.43, 3.99), having radio (AOR = 1.43; 95%CI: 1.05, 1.94) had higher odds of using modern contraceptives compared to their counterparts. Besides, family size of above five (AOR = 0.46; 95% CI: 0.34, 0.62) and living in Somali region (AOR = 0.05; 95% CI: 0.01, 0.32) were associated with decreased odds of using modern contraceptives among young women in Ethiopia. Conclusion: The modern contraceptive use was low among young women and considerably varied across regions in Ethiopia. A remarkably low rate of modern contraceptive use (cold spot) area was detected in Somali region-Ethiopia. Taking in to account a geographic perspective and key factors identified in this study would be vital for efficient resource allocation, targeted interventions, and informed decision-making to enhance contraceptive uptake in Ethiopia.


  • Open Access

    Velamentous cord insertion at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

    by Hailu Aragie, Anteneh Ayelign Kibret, Nahom Worku Teshager, Dagnew Getnet Adugna


  • Open Access

    Incidence and predictors of Tuberculosis among patients enrolled in Anti-Retroviral Therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow -up study

    by Amare Getu, Haileab Fekadu Wolde, Yaregal Animut, Anteneh Ayelign Kibret

    Introduction: Tuberculosis (TB) is the leading killer of people living with HIV (PLHIV) and almost one-third of deaths in the world are attributed to it and many of these deaths occur in developing countries. Despite these evidences, after the implementation of universal test and treat (UTT) strategy, information regarding the incidence and predictors of tuberculosis among PLHIV is limited in Ethiopia. Therefore, this study aimed to assess the incidence and predictors of tuberculosis among patients enrolled in Anti-Retroviral Therapy (ART) after universal test and treat program at St. Peter hospital and Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Methods: Institutional-based retrospective cohort study was conducted from November 1 to 30, 2020. Simple random sampling was used to select a total of 539 adults records which was enrolled on ART. Data was collected and entered into EPI DATA 3.1 and analyzed using STATA version 14.1. Time-to-event distributions were estimated using Kaplan–Meier estimates. Hazards across different categories were compared using log-rank tests. Predictors were identified using the Cox proportional hazards model. The hazard ratio (HR) and 95% confidence interval (CI) were computed. Variables having P-value < 0.05 from the multivariable analysis were considered as a statistically significant. Result: Among 539 records reviewed, 529 (98%) were included in the final analysis. The total follow-up period was 1529 Person-Year (PY). The incidence rate in this cohort was found to be 4.84 per 100-person year (95%CI,3.83–6.11). CD4 count<200 (AHR: 3.14,95% CI:1.64–7.10), poor adherence (AHR:2.16, 95% CI:1.21–3.85), underweight (AHR:2.42, 95% CI: 1.30–4.51), not taking isoniazid prophylaxis therapy (AHR: 2.78,95% CI: 1.06–7.30), being bedridden 3.06; (AHR: 3.06, 95% CI: 1.50–6.24), and baseline WHO stage three or four (AHR:2.33, 95% CI:1.08–5.02) were independent predictors for the incidence of TB among HIV positive patients. Conclusion: In this study, the incidence of tuberculosis is relatively low as compared to studies done before the initiation of test and treat program in Ethiopia. low CD4count, poor level of adherence, low BMI, not taking IPT prophylaxis, bedridden functional status, and being on baseline WHO stage III or IV were found to increase the hazard of tuberculosis. Hence, close follow up, reminders, surveillance, and tracing mechanisms targeting this higher risk group would decrease Tuberculosis among PLHIV.